Price T Rowe Associates Inc. MD Boosts Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Price T Rowe Associates Inc. MD increased its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 8.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 43,596 shares of the medical device company’s stock after buying an additional 3,267 shares during the […]
Price T Rowe Associates Inc. MD increased its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 8.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 43,596 shares of the medical device company’s stock after buying an additional 3,267 shares during the […]
